7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA
IDEAYA Biosciences Files New Automatic Shelf Registration Statement
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Investor Presentation
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence